[1] Gonzalez AJ,Garcia P,Bosch J. Nitric oxide and portalhy pertension. Metad Brain Dis,2002,17(4):311-324. [2] 周永学. 现代肝硬化诊断治疗学. 北京:人民军医出版社,2000:14. [3] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指 南. 实用肝脏病杂志,2006,9(1):8-18. [4] 中华医学会传染病与寄生虫病学分会和肝病分会.病毒性肝炎 防治方案. 中华传染病杂志,2001,19(1):56-62. [5] 庄静,胡建群,王剑翔,等. 新型超声造影剂对肝纤维化-肝硬化定量诊断的研究. 南京医科大学学报(自然科学版),2009,29(8):1164-1166. [6] Abbattista T,Ridolfi F,Ciabattoni E,et al. Diagnosis of liver cirrhosis by transit-time analysis at contrast-enhanced ultrasonography. Radiol Med,2008,113(6):860-874. [7] Ridolfi F,Abbattista T,Marini F,et al. Contrast-enhanced ultrasound to evaluate the severity of chronic hepatitis C. Dig Liver Dis,2007,39(10):929-935. [8] Pedersen JF,Larsen VA,Bytzer P,et al. Hepatic transit time of ultrasound contrast in biopsy characterized liver disease. Acta Radiol,2005,46 (6):557-560. [9] 解丽梅,郭启勇,刘鑫. 超声造影评价肝纤维化. 中国医学影像技术,2009,25(8):1447-1449. [10] Lim AK,Taylor-Robinson SD,Patel N,et al. Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C. Gut,2005,54(1):128-133. [11] Searle J,Mendelson R,Zelesco M,et al. Non-invasive prediction of the degree of liver fibrosis in patients with hepatitis C using an ultrasound contrast agent. A pilot study. J Med Imaging Radiat Oncol,2008,52 (2):130-133. [12] Tang A,Kim TK,Heathcote J,et al. Does hepatic vein transit time performed with contrast-enhanced ultrasound predict the severity of hepatic fibrosis. Ultrasound Med Biol,2011,37(12):1963-1969. [13] Blomley MJ,Lim AK,Harvey CJ,et al. Liver microbubble transit time compared with histology and Child-Pugh score in diffuse liver disease:a cross sectional study. Gut,2003,52(8):1188-1193. |